HCV-话题@MedSci

#HCV#

247篇内容 | 2633人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1257580, encodeId=ac0e125e580dd, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology：HCV患者或可不必使用蛋白酶抑制剂进行治疗, objectType=article, longId=28784, objectId=76fb28e84a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76fb28e84a1, replyNumber=0, likeNumber=29, createdTime=2014-01-03, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76fb28e84a1, moduleTitle=Hepatology：HCV患者或可不必使用蛋白酶抑制剂进行治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76fb28e84a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257579, encodeId=349f125e579af, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology：肝移植围手术期ALC可为移植后HCV早期复发预测指标, objectType=article, longId=28746, objectId=1c5528e4670, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c5528e4670, replyNumber=0, likeNumber=36, createdTime=2014-01-01, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c5528e4670, moduleTitle=Hepatology：肝移植围手术期ALC可为移植后HCV早期复发预测指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c5528e4670)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257578, encodeId=07e2125e578c3, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=BI旗下HCV新药 Faldaprevir获欧洲加速审评资格, objectType=article, longId=27440, objectId=70d62e4402f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70d62e4402f, replyNumber=0, likeNumber=38, createdTime=2013-12-04, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70d62e4402f, moduleTitle=BI旗下HCV新药 Faldaprevir获欧洲加速审评资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70d62e4402f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257577, encodeId=aedd125e57735, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=JID：人乳具抗HCV活性, objectType=article, longId=26584, objectId=a53f265848d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a53f265848d, replyNumber=0, likeNumber=31, createdTime=2013-11-15, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a53f265848d, moduleTitle=JID：人乳具抗HCV活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a53f265848d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257576, encodeId=80c6125e57618, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Gastroenterology：降低利巴韦林剂量为控制三联治疗1型HCV感染患者继发贫血的**方案, objectType=article, longId=26580, objectId=5fbf26580ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fbf26580ec, replyNumber=0, likeNumber=20, createdTime=2013-11-15, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fbf26580ec, moduleTitle=Gastroenterology：降低利巴韦林剂量为控制三联治疗1型HCV感染患者继发贫血的**方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fbf26580ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257575, encodeId=fd2b125e575fd, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Nature：新型丙肝口服药物获批上市人类将首次战胜HCV, objectType=article, longId=26246, objectId=16012624687, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16012624687, replyNumber=0, likeNumber=34, createdTime=2013-11-07, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16012624687, moduleTitle=Nature：新型丙肝口服药物获批上市人类将首次战胜HCV, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16012624687)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257574, encodeId=413e125e574f9, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=百时美在日本提交HCV全口服方案新药申请, objectType=article, longId=26221, objectId=84af2622184, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84af2622184, replyNumber=0, likeNumber=37, createdTime=2013-11-07, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84af2622184, moduleTitle=百时美在日本提交HCV全口服方案新药申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84af2622184)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257573, encodeId=fcb0125e57374, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=JID：1b期研究发现ITX5061治疗HCV效果有限, objectType=article, longId=26084, objectId=4fbe260846c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fbe260846c, replyNumber=0, likeNumber=40, createdTime=2013-11-02, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fbe260846c, moduleTitle=JID：1b期研究发现ITX5061治疗HCV效果有限, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fbe260846c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257572, encodeId=d67b125e572ab, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=CID：美国HBV或HCV感染者寿命比未感染者短22-23年, objectType=article, longId=25259, objectId=faf425259d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=faf425259d6, replyNumber=0, likeNumber=34, createdTime=2013-10-11, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=faf425259d6, moduleTitle=CID：美国HBV或HCV感染者寿命比未感染者短22-23年, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=faf425259d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257571, encodeId=15d3125e57123, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J HEPATOL：HBsAg水平和白介素-28B基因型可预测尿毒症患者HCV的自发清除率, objectType=article, longId=25249, objectId=9776252499c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9776252499c, replyNumber=0, likeNumber=28, createdTime=2013-10-11, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9776252499c, moduleTitle=J HEPATOL：HBsAg水平和白介素-28B基因型可预测尿毒症患者HCV的自发清除率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9776252499c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257570, encodeId=cfe1125e570cd, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=JID：HCV血清阳性增加HIV患者患慢性肾病的风险, objectType=article, longId=24201, objectId=477c242014d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=477c242014d, replyNumber=0, likeNumber=32, createdTime=2013-09-12, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=477c242014d, moduleTitle=JID：HCV血清阳性增加HIV患者患慢性肾病的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=477c242014d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257569, encodeId=9d16125e5690c, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=勃林格殷格翰2个关键III期HCV研究完成患者招募, objectType=article, longId=23133, objectId=53fa231339d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53fa231339d, replyNumber=0, likeNumber=42, createdTime=2013-08-21, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53fa231339d, moduleTitle=勃林格殷格翰2个关键III期HCV研究完成患者招募, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53fa231339d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257568, encodeId=67c3125e56805, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=IL-17及血浆水平与HCV感染的关系, objectType=article, longId=21999, objectId=0c53219998d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c53219998d, replyNumber=0, likeNumber=37, createdTime=2013-07-26, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c53219998d, moduleTitle=IL-17及血浆水平与HCV感染的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c53219998d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257567, encodeId=ca33125e5675d, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=FDA批准雅培HCV基因型检测试剂盒上市, objectType=article, longId=21380, objectId=378b21380f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=378b21380f4, replyNumber=0, likeNumber=35, createdTime=2013-07-15, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=378b21380f4, moduleTitle=FDA批准雅培HCV基因型检测试剂盒上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=378b21380f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257566, encodeId=3b13125e5669f, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=[EASL2013]基因2/3型经治HCV患者接受SOF+RBV治疗疗效好, objectType=article, longId=18847, objectId=b4e91884e53, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4e91884e53, replyNumber=0, likeNumber=37, createdTime=2013-05-18, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4e91884e53, moduleTitle=[EASL2013]基因2/3型经治HCV患者接受SOF+RBV治疗疗效好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4e91884e53)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257565, encodeId=6682125e565e1, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Oncol Rep：首都医科大学贾继东等发现肝细胞癌的TP53突变与HCV阳性相关, objectType=article, longId=18503, objectId=80f018503d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80f018503d8, replyNumber=0, likeNumber=40, createdTime=2013-05-11, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80f018503d8, moduleTitle=Oncol Rep：首都医科大学贾继东等发现肝细胞癌的TP53突变与HCV阳性相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80f018503d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257564, encodeId=7978125e56492, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=PLoS Pathog：单克隆抗体HCV1有望治疗丙型肝炎, objectType=article, longId=18143, objectId=60e218143e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60e218143e3, replyNumber=0, likeNumber=23, createdTime=2013-05-08, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60e218143e3, moduleTitle=PLoS Pathog：单克隆抗体HCV1有望治疗丙型肝炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60e218143e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257563, encodeId=b925125e56335, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=CID：HCV相关肝硬化患者实现SVR后仍长期处于肝细胞癌风险中, objectType=article, longId=17947, objectId=c80e1e9470f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c80e1e9470f, replyNumber=0, likeNumber=26, createdTime=2013-05-08, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c80e1e9470f, moduleTitle=CID：HCV相关肝硬化患者实现SVR后仍长期处于肝细胞癌风险中, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c80e1e9470f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257562, encodeId=3bf9125e562b4, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=NEJM：Sofosbuvir可有效治疗基因2型或3型HCV感染, objectType=article, longId=17878, objectId=450f1e8784d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=450f1e8784d, replyNumber=0, likeNumber=36, createdTime=2013-05-02, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=450f1e8784d, moduleTitle=NEJM：Sofosbuvir可有效治疗基因2型或3型HCV感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=450f1e8784d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257561, encodeId=9285125e5613c, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J HEPATOL：无黄疸且IL28B CT/TT型AHC患者缺乏HCV清除能力, objectType=article, longId=17587, objectId=ab7b1e58708, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab7b1e58708, replyNumber=0, likeNumber=39, createdTime=2013-04-21, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab7b1e58708, moduleTitle=J HEPATOL：无黄疸且IL28B CT/TT型AHC患者缺乏HCV清除能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab7b1e58708)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HCV

2020-05-29

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology：HCV患者或可不必使用蛋白酶抑制剂进行治疗

2014-01-03

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology：肝移植围手术期ALC可为移植后HCV早期复发预测指标

2014-01-01

ymljack (审核中...)

前往app查看评论内容

#HCV#

BI旗下HCV新药 Faldaprevir获欧洲加速审评资格

2013-12-04

ymljack (审核中...)

前往app查看评论内容

#HCV#

JID：人乳具抗HCV活性

2013-11-15

ymljack (审核中...)

前往app查看评论内容

#HCV#

Gastroenterology：降低利巴韦林剂量为控制三联治疗1型HCV感染患者继发贫血的**方案

2013-11-15

ymljack (审核中...)

前往app查看评论内容

#HCV#

Nature：新型丙肝口服药物获批上市人类将首次战胜HCV

2013-11-07

ymljack (审核中...)

前往app查看评论内容

#HCV#

百时美在日本提交HCV全口服方案新药申请

2013-11-07

ymljack (审核中...)

前往app查看评论内容

#HCV#

JID：1b期研究发现ITX5061治疗HCV效果有限

2013-11-02

ymljack (审核中...)

前往app查看评论内容

#HCV#

CID：美国HBV或HCV感染者寿命比未感染者短22-23年

2013-10-11

ymljack (审核中...)

前往app查看评论内容

#HCV#

J HEPATOL：HBsAg水平和白介素-28B基因型可预测尿毒症患者HCV的自发清除率

2013-10-11

ymljack (审核中...)

前往app查看评论内容

#HCV#

JID：HCV血清阳性增加HIV患者患慢性肾病的风险

2013-09-12

ymljack (审核中...)

前往app查看评论内容

#HCV#

勃林格殷格翰2个关键III期HCV研究完成患者招募

2013-08-21

ymljack (审核中...)

前往app查看评论内容

#HCV#

IL-17及血浆水平与HCV感染的关系

2013-07-26

ymljack (审核中...)

前往app查看评论内容

#HCV#

FDA批准雅培HCV基因型检测试剂盒上市

2013-07-15

ymljack (审核中...)

前往app查看评论内容

#HCV#

[EASL2013]基因2/3型经治HCV患者接受SOF+RBV治疗疗效好

2013-05-18

ymljack (审核中...)

前往app查看评论内容

#HCV#

Oncol Rep：首都医科大学贾继东等发现肝细胞癌的TP53突变与HCV阳性相关

2013-05-11

ymljack (审核中...)

前往app查看评论内容

#HCV#

PLoS Pathog：单克隆抗体HCV1有望治疗丙型肝炎

2013-05-08

ymljack (审核中...)

前往app查看评论内容

#HCV#

CID：HCV相关肝硬化患者实现SVR后仍长期处于肝细胞癌风险中

2013-05-08

ymljack (审核中...)

前往app查看评论内容

#HCV#

NEJM：Sofosbuvir可有效治疗基因2型或3型HCV感染

2013-05-02

ymljack (审核中...)

前往app查看评论内容

#HCV#

J HEPATOL：无黄疸且IL28B CT/TT型AHC患者缺乏HCV清除能力

2013-04-21

科室
- - 订阅+
  - 更多科室
工具
服务